| 1 | idiopathic | 2,680 |
| 2 | subclinical | 2,357 |
| 3 | neurogenic | 894 |
| 4 | overactive | 684 |
| 5 | incipient | 168 |
| 6 | vancomycin-resistant | 162 |
| 7 | opioid-induced | 144 |
| 8 | gall | 109 |
| 9 | muscle-invasive | 109 |
| 10 | non-ulcer | 98 |
| 11 | pyogenic | 87 |
| 12 | sub-clinical | 83 |
| 13 | vasculogenic | 77 |
| 14 | sepsis-induced | 73 |
| 15 | non-muscle-invasive | 68 |
| 16 | spasmodic | 55 |
| 17 | prethreshold | 54 |
| 18 | arteriogenic | 42 |
| 19 | hypertension-induced | 38 |
| 20 | nonulcer | 35 |
| 21 | schistosomal | 35 |
| 22 | papulopustular | 32 |
| 23 | uninhibited | 30 |
| 24 | polyarticular | 29 |
| 25 | involutional | 28 |
| 26 | non-neurogenic | 27 |
| 27 | obliterating | 27 |
| 28 | finch | 25 |
| 29 | clomiphene-resistant | 24 |
| 30 | underactive | 23 |
| 31 | pre-capillary | 20 |
| 32 | low-compliance | 17 |
| 33 | amiodarone-induced | 16 |
| 34 | lazy | 15 |
| 35 | nonneurogenic | 15 |
| 36 | ppi-refractory | 15 |
| 37 | load-induced | 14 |
| 38 | nepean | 14 |
| 39 | slow-transit | 14 |
| 40 | defunctionalized | 13 |
| 41 | ht-related | 12 |
| 42 | nonmuscle-invasive | 12 |
| 43 | polyarticular-course | 12 |
| 44 | areflexic | 11 |
| 45 | non-massive | 11 |
| 46 | radiation-associated | 11 |
| 47 | sub-healthy | 11 |
| 48 | nonocclusive | 9 |
| 49 | nonresolving | 9 |
| 50 | prelingual | 9 |
| 51 | adult-type | 8 |
| 52 | crt-induced | 8 |
| 53 | goitrous | 8 |
| 54 | infraclinical | 8 |
| 55 | intermediate-1-risk | 8 |
| 56 | shunt-related | 8 |
| 57 | steroid-unresponsive | 8 |
| 58 | systemic-onset | 8 |
| 59 | bilharzial | 7 |
| 60 | destruction-induced | 7 |
| 61 | dysmotility-like | 7 |
| 62 | scleroderma-associated | 7 |
| 63 | scleroderma-related | 7 |
| 64 | tuberculoid | 7 |
| 65 | mizone | 6 |
| 66 | non-bullous | 6 |
| 67 | nonautoimmune | 6 |
| 68 | pn-associated | 6 |
| 69 | pyretic | 6 |
| 70 | reverse-remodeled | 6 |
| 71 | cardiology/european | 5 |
| 72 | clomiphene-citrate-resistant | 5 |
| 73 | nonsegmental | 5 |
| 74 | organ-selective | 5 |
| 75 | ragweed-induced | 5 |
| 76 | sunitinib-associated | 5 |
| 77 | tcrb-positive | 5 |
| 78 | ulcer-like | 5 |
| 79 | 'overactive | 4 |
| 80 | 'renal | 4 |
| 81 | bh4-responsive | 4 |
| 82 | brachytherapy-related | 4 |
| 83 | cmv-related | 4 |
| 84 | dyshormonogenetic | 4 |
| 85 | extraparenchymal | 4 |
| 86 | hyperthyroidism-induced | 4 |
| 87 | hypocompliant | 4 |
| 88 | low-capacity | 4 |
| 89 | normal-pressure | 4 |
| 90 | obesity-type | 4 |
| 91 | osteodistraction | 4 |
| 92 | pre-lingual | 4 |
| 93 | ptsd-associated | 4 |
| 94 | sensodyne® | 4 |
| 95 | t+5-ht | 4 |
| 96 | ultrasound-visible | 4 |
| 97 | anorexigen-associated | 3 |
| 98 | autopsy-proven | 3 |
| 99 | cat-induced | 3 |
| 100 | dmard-refractory | 3 |
| 101 | htb-4 | 3 |
| 102 | hyperprolactinemia-induced | 3 |
| 103 | ifnα-induced | 3 |
| 104 | inflammation/clinical | 3 |
| 105 | normogonadotropic | 3 |
| 106 | post-withdrawal | 3 |
| 107 | postlingual | 3 |
| 108 | prefibrotic | 3 |
| 109 | prostanoid-induced | 3 |
| 110 | rheumatology-defined | 3 |
| 111 | salpingitic | 3 |
| 112 | shunt-dependent | 3 |
| 113 | sle-related | 3 |
| 114 | sleep-maintenance | 3 |
| 115 | suprasystemic | 3 |
| 116 | tuskegee | 3 |
| 117 | 'lazy | 2 |
| 118 | /painful | 2 |
| 119 | 1540-nm | 2 |
| 120 | 7,827 | 2 |
| 121 | acontractile | 2 |
| 122 | anaesthetic-induced | 2 |
| 123 | angio-obliterative | 2 |
| 124 | bladder/idiopathic | 2 |
| 125 | cd33+ | 2 |
| 126 | cholestyramine-induced | 2 |
| 127 | clival | 2 |
| 128 | cystitis-related | 2 |
| 129 | diag- | 2 |
| 130 | donor-transmitted | 2 |
| 131 | drug-intolerant | 2 |
| 132 | dsm-5-defined | 2 |
| 133 | fibrinonecrotic | 2 |
| 134 | hctz-induced | 2 |
| 135 | hhe-related | 2 |
| 136 | hypomagnesemia-associated | 2 |
| 137 | hyporeflexic | 2 |
| 138 | i3c-induced | 2 |
| 139 | injury-neurogenic | 2 |
| 140 | lenalidomide-induced | 2 |
| 141 | microadenoma-related | 2 |
| 142 | multiloculated | 2 |
| 143 | muscle-invading | 2 |
| 144 | neuropatic | 2 |
| 145 | newly-onset | 2 |
| 146 | nisseria | 2 |
| 147 | non-arterial | 2 |
| 148 | non-congenital | 2 |
| 149 | non-medullary | 2 |
| 150 | nonbullous | 2 |
| 151 | post-cesarean-section | 2 |
| 152 | post-infective | 2 |
| 153 | rifampin-sensitive | 2 |
| 154 | seizure-associated | 2 |
| 155 | teilo | 2 |
| 156 | uv-killed | 2 |
| 157 | ''ocular | 1 |
| 158 | -overactive | 1 |
| 159 | 13,894 | 1 |
| 160 | 3'-full | 1 |
| 161 | 3,461,151 | 1 |
| 162 | 3088142 | 1 |
| 163 | 53,949 | 1 |
| 164 | 69,740 | 1 |
| 165 | airway-centred | 1 |
| 166 | anti-ovine | 1 |
| 167 | anti-tnf-eligible | 1 |
| 168 | anti-vancomycin-resistant | 1 |
| 169 | antibiotic-naive | 1 |
| 170 | antibiotic-naïve | 1 |
| 171 | asw-associated | 1 |
| 172 | autoimmunized | 1 |
| 173 | available.is | 1 |
| 174 | bd-infected | 1 |
| 175 | boari-küss | 1 |
| 176 | caps-measured | 1 |
| 177 | cck-induced | 1 |
| 178 | ceftriaxone-associated | 1 |
| 179 | characteristic-appearing | 1 |
| 180 | chlorocadmium | 1 |
| 181 | cogenital | 1 |
| 182 | constipation/idiopathic | 1 |
| 183 | crh-treated | 1 |
| 184 | ctd-associated | 1 |
| 185 | deep-brain-stimulation-induced | 1 |
| 186 | dextrolateral | 1 |
| 187 | dilated-phase | 1 |
| 188 | effectiveness.point-of-care | 1 |
| 189 | egg-related | 1 |
| 190 | endothelial-lined | 1 |
| 191 | evidenceof | 1 |
| 192 | exstrophic | 1 |
| 193 | extra-vesical | 1 |
| 194 | football-associated | 1 |
| 195 | groups-concentric | 1 |
| 196 | hht-associated | 1 |
| 197 | hht-related | 1 |
| 198 | htn-induced | 1 |
| 199 | hypercholesteremia-induced | 1 |
| 200 | hypo-and | 1 |
| 201 | idiophathic | 1 |
| 202 | indewelling | 1 |
| 203 | insulin/glp-1 | 1 |
| 204 | insulinic | 1 |
| 205 | iodine-131-refractory | 1 |
| 206 | iodine-induced | 1 |
| 207 | j-wave-associated | 1 |
| 208 | keratitis-ichthyosis | 1 |
| 209 | ketamine-reversible | 1 |
| 210 | l-thyroxin-induced | 1 |
| 211 | lagomorph-specific | 1 |
| 212 | lidiopathic | 1 |
| 213 | metacarpic | 1 |
| 214 | methimazole-induced | 1 |
| 215 | metoclopramide-dihydrochloride-induced | 1 |
| 216 | mooney-ewart | 1 |
| 217 | moxifloxacin-sensitive | 1 |
| 218 | multiglandular | 1 |
| 219 | multiocular | 1 |
| 220 | muscleinvading | 1 |
| 221 | nitroimidazole-refractory | 1 |
| 222 | non-bilharzial | 1 |
| 223 | non-investigated/functional | 1 |
| 224 | non-rituximab | 1 |
| 225 | non-schistosomal | 1 |
| 226 | non-shunted | 1 |
| 227 | non-ulcerous | 1 |
| 228 | nonhematogenous | 1 |
| 229 | nonsecreting | 1 |
| 230 | nonucler | 1 |
| 231 | nonurethral | 1 |
| 232 | normal-transit | 1 |
| 233 | normo-active | 1 |
| 234 | olfloxacin-resistant | 1 |
| 235 | oveactive | 1 |
| 236 | overt/subclinical | 1 |
| 237 | papillar | 1 |
| 238 | parasitologically-demonstrated | 1 |
| 239 | participant-completed | 1 |
| 240 | plasmacellular | 1 |
| 241 | poly-districtual | 1 |
| 242 | post-carv | 1 |
| 243 | postecsarean | 1 |
| 244 | postinfective | 1 |
| 245 | prymary | 1 |
| 246 | pth-deficient | 1 |
| 247 | ptu-induced | 1 |
| 248 | removedfrom | 1 |
| 249 | reptile-related | 1 |
| 250 | resin-induced | 1 |
| 251 | ribosome-free | 1 |
| 252 | sapropterin-treated | 1 |
| 253 | seborrhoeic/staphylococcal | 1 |
| 254 | seen-the | 1 |
| 255 | serum-intact | 1 |
| 256 | services-captured | 1 |
| 257 | shunt-treated | 1 |
| 258 | slide-confirmed | 1 |
| 259 | sod1-positive | 1 |
| 260 | solid/multicystic | 1 |
| 261 | subhealthy | 1 |
| 262 | t1-t4a | 1 |
| 263 | t1g3/t2 | 1 |
| 264 | tegu | 1 |
| 265 | telangiectasia-related | 1 |
| 266 | thiouracil-induced | 1 |
| 267 | tumorogenic | 1 |
| 268 | ugs-induced | 1 |
| 269 | ultrasonography-measured | 1 |
| 270 | unobstructive | 1 |
| 271 | urine-deprived | 1 |
| 272 | urticaria/spontaneous | 1 |
| 273 | vancomycine-resistant | 1 |
| 274 | verapamil-sensitive | 1 |
| 275 | young-dees-leadbetter | 1 |
| 1 | ''ocular | 1 |
| 2 | 'lazy | 2 |
| 3 | 'overactive | 4 |
| 4 | 'renal | 4 |
| 5 | -overactive | 1 |
| 6 | /painful | 2 |
| 7 | 13,894 | 1 |
| 8 | 1540-nm | 2 |
| 9 | 3'-full | 1 |
| 10 | 3,461,151 | 1 |
| 11 | 3088142 | 1 |
| 12 | 53,949 | 1 |
| 13 | 69,740 | 1 |
| 14 | 7,827 | 2 |
| 15 | acontractile | 2 |
| 16 | adult-type | 8 |
| 17 | airway-centred | 1 |
| 18 | amiodarone-induced | 16 |
| 19 | anaesthetic-induced | 2 |
| 20 | angio-obliterative | 2 |
| 21 | anorexigen-associated | 3 |
| 22 | anti-ovine | 1 |
| 23 | anti-tnf-eligible | 1 |
| 24 | anti-vancomycin-resistant | 1 |
| 25 | antibiotic-naive | 1 |
| 26 | antibiotic-naïve | 1 |
| 27 | areflexic | 11 |
| 28 | arteriogenic | 42 |
| 29 | asw-associated | 1 |
| 30 | autoimmunized | 1 |
| 31 | autopsy-proven | 3 |
| 32 | available.is | 1 |
| 33 | bd-infected | 1 |
| 34 | bh4-responsive | 4 |
| 35 | bilharzial | 7 |
| 36 | bladder/idiopathic | 2 |
| 37 | boari-küss | 1 |
| 38 | brachytherapy-related | 4 |
| 39 | caps-measured | 1 |
| 40 | cardiology/european | 5 |
| 41 | cat-induced | 3 |
| 42 | cck-induced | 1 |
| 43 | cd33+ | 2 |
| 44 | ceftriaxone-associated | 1 |
| 45 | characteristic-appearing | 1 |
| 46 | chlorocadmium | 1 |
| 47 | cholestyramine-induced | 2 |
| 48 | clival | 2 |
| 49 | clomiphene-citrate-resistant | 5 |
| 50 | clomiphene-resistant | 24 |
| 51 | cmv-related | 4 |
| 52 | cogenital | 1 |
| 53 | constipation/idiopathic | 1 |
| 54 | crh-treated | 1 |
| 55 | crt-induced | 8 |
| 56 | ctd-associated | 1 |
| 57 | cystitis-related | 2 |
| 58 | deep-brain-stimulation-induced | 1 |
| 59 | defunctionalized | 13 |
| 60 | destruction-induced | 7 |
| 61 | dextrolateral | 1 |
| 62 | diag- | 2 |
| 63 | dilated-phase | 1 |
| 64 | dmard-refractory | 3 |
| 65 | donor-transmitted | 2 |
| 66 | drug-intolerant | 2 |
| 67 | dsm-5-defined | 2 |
| 68 | dyshormonogenetic | 4 |
| 69 | dysmotility-like | 7 |
| 70 | effectiveness.point-of-care | 1 |
| 71 | egg-related | 1 |
| 72 | endothelial-lined | 1 |
| 73 | evidenceof | 1 |
| 74 | exstrophic | 1 |
| 75 | extra-vesical | 1 |
| 76 | extraparenchymal | 4 |
| 77 | fibrinonecrotic | 2 |
| 78 | finch | 25 |
| 79 | football-associated | 1 |
| 80 | gall | 109 |
| 81 | goitrous | 8 |
| 82 | groups-concentric | 1 |
| 83 | hctz-induced | 2 |
| 84 | hhe-related | 2 |
| 85 | hht-associated | 1 |
| 86 | hht-related | 1 |
| 87 | ht-related | 12 |
| 88 | htb-4 | 3 |
| 89 | htn-induced | 1 |
| 90 | hypercholesteremia-induced | 1 |
| 91 | hyperprolactinemia-induced | 3 |
| 92 | hypertension-induced | 38 |
| 93 | hyperthyroidism-induced | 4 |
| 94 | hypo-and | 1 |
| 95 | hypocompliant | 4 |
| 96 | hypomagnesemia-associated | 2 |
| 97 | hyporeflexic | 2 |
| 98 | i3c-induced | 2 |
| 99 | idiopathic | 2,680 |
| 100 | idiophathic | 1 |
| 101 | ifnα-induced | 3 |
| 102 | incipient | 168 |
| 103 | indewelling | 1 |
| 104 | inflammation/clinical | 3 |
| 105 | infraclinical | 8 |
| 106 | injury-neurogenic | 2 |
| 107 | insulin/glp-1 | 1 |
| 108 | insulinic | 1 |
| 109 | intermediate-1-risk | 8 |
| 110 | involutional | 28 |
| 111 | iodine-131-refractory | 1 |
| 112 | iodine-induced | 1 |
| 113 | j-wave-associated | 1 |
| 114 | keratitis-ichthyosis | 1 |
| 115 | ketamine-reversible | 1 |
| 116 | l-thyroxin-induced | 1 |
| 117 | lagomorph-specific | 1 |
| 118 | lazy | 15 |
| 119 | lenalidomide-induced | 2 |
| 120 | lidiopathic | 1 |
| 121 | load-induced | 14 |
| 122 | low-capacity | 4 |
| 123 | low-compliance | 17 |
| 124 | metacarpic | 1 |
| 125 | methimazole-induced | 1 |
| 126 | metoclopramide-dihydrochloride-induced | 1 |
| 127 | microadenoma-related | 2 |
| 128 | mizone | 6 |
| 129 | mooney-ewart | 1 |
| 130 | moxifloxacin-sensitive | 1 |
| 131 | multiglandular | 1 |
| 132 | multiloculated | 2 |
| 133 | multiocular | 1 |
| 134 | muscle-invading | 2 |
| 135 | muscle-invasive | 109 |
| 136 | muscleinvading | 1 |
| 137 | nepean | 14 |
| 138 | neurogenic | 894 |
| 139 | neuropatic | 2 |
| 140 | newly-onset | 2 |
| 141 | nisseria | 2 |
| 142 | nitroimidazole-refractory | 1 |
| 143 | non-arterial | 2 |
| 144 | non-bilharzial | 1 |
| 145 | non-bullous | 6 |
| 146 | non-congenital | 2 |
| 147 | non-investigated/functional | 1 |
| 148 | non-massive | 11 |
| 149 | non-medullary | 2 |
| 150 | non-muscle-invasive | 68 |
| 151 | non-neurogenic | 27 |
| 152 | non-rituximab | 1 |
| 153 | non-schistosomal | 1 |
| 154 | non-shunted | 1 |
| 155 | non-ulcer | 98 |
| 156 | non-ulcerous | 1 |
| 157 | nonautoimmune | 6 |
| 158 | nonbullous | 2 |
| 159 | nonhematogenous | 1 |
| 160 | nonmuscle-invasive | 12 |
| 161 | nonneurogenic | 15 |
| 162 | nonocclusive | 9 |
| 163 | nonresolving | 9 |
| 164 | nonsecreting | 1 |
| 165 | nonsegmental | 5 |
| 166 | nonucler | 1 |
| 167 | nonulcer | 35 |
| 168 | nonurethral | 1 |
| 169 | normal-pressure | 4 |
| 170 | normal-transit | 1 |
| 171 | normo-active | 1 |
| 172 | normogonadotropic | 3 |
| 173 | obesity-type | 4 |
| 174 | obliterating | 27 |
| 175 | olfloxacin-resistant | 1 |
| 176 | opioid-induced | 144 |
| 177 | organ-selective | 5 |
| 178 | osteodistraction | 4 |
| 179 | oveactive | 1 |
| 180 | overactive | 684 |
| 181 | overt/subclinical | 1 |
| 182 | papillar | 1 |
| 183 | papulopustular | 32 |
| 184 | parasitologically-demonstrated | 1 |
| 185 | participant-completed | 1 |
| 186 | plasmacellular | 1 |
| 187 | pn-associated | 6 |
| 188 | poly-districtual | 1 |
| 189 | polyarticular | 29 |
| 190 | polyarticular-course | 12 |
| 191 | post-carv | 1 |
| 192 | post-cesarean-section | 2 |
| 193 | post-infective | 2 |
| 194 | post-withdrawal | 3 |
| 195 | postecsarean | 1 |
| 196 | postinfective | 1 |
| 197 | postlingual | 3 |
| 198 | ppi-refractory | 15 |
| 199 | pre-capillary | 20 |
| 200 | pre-lingual | 4 |
| 201 | prefibrotic | 3 |
| 202 | prelingual | 9 |
| 203 | prethreshold | 54 |
| 204 | prostanoid-induced | 3 |
| 205 | prymary | 1 |
| 206 | pth-deficient | 1 |
| 207 | ptsd-associated | 4 |
| 208 | ptu-induced | 1 |
| 209 | pyogenic | 87 |
| 210 | pyretic | 6 |
| 211 | radiation-associated | 11 |
| 212 | ragweed-induced | 5 |
| 213 | removedfrom | 1 |
| 214 | reptile-related | 1 |
| 215 | resin-induced | 1 |
| 216 | reverse-remodeled | 6 |
| 217 | rheumatology-defined | 3 |
| 218 | ribosome-free | 1 |
| 219 | rifampin-sensitive | 2 |
| 220 | salpingitic | 3 |
| 221 | sapropterin-treated | 1 |
| 222 | schistosomal | 35 |
| 223 | scleroderma-associated | 7 |
| 224 | scleroderma-related | 7 |
| 225 | seborrhoeic/staphylococcal | 1 |
| 226 | seen-the | 1 |
| 227 | seizure-associated | 2 |
| 228 | sensodyne® | 4 |
| 229 | sepsis-induced | 73 |
| 230 | serum-intact | 1 |
| 231 | services-captured | 1 |
| 232 | shunt-dependent | 3 |
| 233 | shunt-related | 8 |
| 234 | shunt-treated | 1 |
| 235 | sle-related | 3 |
| 236 | sleep-maintenance | 3 |
| 237 | slide-confirmed | 1 |
| 238 | slow-transit | 14 |
| 239 | sod1-positive | 1 |
| 240 | solid/multicystic | 1 |
| 241 | spasmodic | 55 |
| 242 | steroid-unresponsive | 8 |
| 243 | sub-clinical | 83 |
| 244 | sub-healthy | 11 |
| 245 | subclinical | 2,357 |
| 246 | subhealthy | 1 |
| 247 | sunitinib-associated | 5 |
| 248 | suprasystemic | 3 |
| 249 | systemic-onset | 8 |
| 250 | t+5-ht | 4 |
| 251 | t1-t4a | 1 |
| 252 | t1g3/t2 | 1 |
| 253 | tcrb-positive | 5 |
| 254 | tegu | 1 |
| 255 | teilo | 2 |
| 256 | telangiectasia-related | 1 |
| 257 | thiouracil-induced | 1 |
| 258 | tuberculoid | 7 |
| 259 | tumorogenic | 1 |
| 260 | tuskegee | 3 |
| 261 | ugs-induced | 1 |
| 262 | ulcer-like | 5 |
| 263 | ultrasonography-measured | 1 |
| 264 | ultrasound-visible | 4 |
| 265 | underactive | 23 |
| 266 | uninhibited | 30 |
| 267 | unobstructive | 1 |
| 268 | urine-deprived | 1 |
| 269 | urticaria/spontaneous | 1 |
| 270 | uv-killed | 2 |
| 271 | vancomycin-resistant | 162 |
| 272 | vancomycine-resistant | 1 |
| 273 | vasculogenic | 77 |
| 274 | verapamil-sensitive | 1 |
| 275 | young-dees-leadbetter | 1 |
| 1 | cd33+ | 2 |
| 2 | diag- | 2 |
| 3 | 69,740 | 1 |
| 4 | insulin/glp-1 | 1 |
| 5 | 3,461,151 | 1 |
| 6 | 3088142 | 1 |
| 7 | t1g3/t2 | 1 |
| 8 | htb-4 | 3 |
| 9 | 13,894 | 1 |
| 10 | 7,827 | 2 |
| 11 | 53,949 | 1 |
| 12 | t1-t4a | 1 |
| 13 | nisseria | 2 |
| 14 | non-rituximab | 1 |
| 15 | spasmodic | 55 |
| 16 | lagomorph-specific | 1 |
| 17 | exstrophic | 1 |
| 18 | idiophathic | 1 |
| 19 | idiopathic | 2,680 |
| 20 | constipation/idiopathic | 1 |
| 21 | bladder/idiopathic | 2 |
| 22 | lidiopathic | 1 |
| 23 | suprasystemic | 3 |
| 24 | arteriogenic | 42 |
| 25 | vasculogenic | 77 |
| 26 | tumorogenic | 1 |
| 27 | neurogenic | 894 |
| 28 | non-neurogenic | 27 |
| 29 | injury-neurogenic | 2 |
| 30 | nonneurogenic | 15 |
| 31 | pyogenic | 87 |
| 32 | insulinic | 1 |
| 33 | normogonadotropic | 3 |
| 34 | metacarpic | 1 |
| 35 | groups-concentric | 1 |
| 36 | neuropatic | 2 |
| 37 | dyshormonogenetic | 4 |
| 38 | pyretic | 6 |
| 39 | salpingitic | 3 |
| 40 | prefibrotic | 3 |
| 41 | fibrinonecrotic | 2 |
| 42 | solid/multicystic | 1 |
| 43 | areflexic | 11 |
| 44 | hyporeflexic | 2 |
| 45 | hyperprolactinemia-induced | 3 |
| 46 | hypercholesteremia-induced | 1 |
| 47 | i3c-induced | 2 |
| 48 | anaesthetic-induced | 2 |
| 49 | load-induced | 14 |
| 50 | ragweed-induced | 5 |
| 51 | opioid-induced | 144 |
| 52 | prostanoid-induced | 3 |
| 53 | lenalidomide-induced | 2 |
| 54 | metoclopramide-dihydrochloride-induced | 1 |
| 55 | methimazole-induced | 1 |
| 56 | iodine-induced | 1 |
| 57 | cholestyramine-induced | 2 |
| 58 | amiodarone-induced | 16 |
| 59 | cck-induced | 1 |
| 60 | thiouracil-induced | 1 |
| 61 | hyperthyroidism-induced | 4 |
| 62 | resin-induced | 1 |
| 63 | l-thyroxin-induced | 1 |
| 64 | hypertension-induced | 38 |
| 65 | deep-brain-stimulation-induced | 1 |
| 66 | destruction-induced | 7 |
| 67 | htn-induced | 1 |
| 68 | ugs-induced | 1 |
| 69 | sepsis-induced | 73 |
| 70 | cat-induced | 3 |
| 71 | crt-induced | 8 |
| 72 | ptu-induced | 1 |
| 73 | hctz-induced | 2 |
| 74 | ifnα-induced | 3 |
| 75 | reverse-remodeled | 6 |
| 76 | uv-killed | 2 |
| 77 | slide-confirmed | 1 |
| 78 | dsm-5-defined | 2 |
| 79 | rheumatology-defined | 3 |
| 80 | endothelial-lined | 1 |
| 81 | airway-centred | 1 |
| 82 | caps-measured | 1 |
| 83 | ultrasonography-measured | 1 |
| 84 | services-captured | 1 |
| 85 | crh-treated | 1 |
| 86 | sapropterin-treated | 1 |
| 87 | shunt-treated | 1 |
| 88 | hypomagnesemia-associated | 2 |
| 89 | scleroderma-associated | 7 |
| 90 | sunitinib-associated | 5 |
| 91 | ptsd-associated | 4 |
| 92 | ctd-associated | 1 |
| 93 | ceftriaxone-associated | 1 |
| 94 | seizure-associated | 2 |
| 95 | j-wave-associated | 1 |
| 96 | football-associated | 1 |
| 97 | anorexigen-associated | 3 |
| 98 | radiation-associated | 11 |
| 99 | pn-associated | 6 |
| 100 | hht-associated | 1 |
| 101 | asw-associated | 1 |
| 102 | telangiectasia-related | 1 |
| 103 | microadenoma-related | 2 |
| 104 | scleroderma-related | 7 |
| 105 | hhe-related | 2 |
| 106 | reptile-related | 1 |
| 107 | sle-related | 3 |
| 108 | egg-related | 1 |
| 109 | cystitis-related | 2 |
| 110 | ht-related | 12 |
| 111 | hht-related | 1 |
| 112 | shunt-related | 8 |
| 113 | cmv-related | 4 |
| 114 | brachytherapy-related | 4 |
| 115 | multiloculated | 2 |
| 116 | parasitologically-demonstrated | 1 |
| 117 | bd-infected | 1 |
| 118 | participant-completed | 1 |
| 119 | uninhibited | 30 |
| 120 | non-shunted | 1 |
| 121 | donor-transmitted | 2 |
| 122 | urine-deprived | 1 |
| 123 | defunctionalized | 13 |
| 124 | autoimmunized | 1 |
| 125 | tuberculoid | 7 |
| 126 | prethreshold | 54 |
| 127 | hypo-and | 1 |
| 128 | low-compliance | 17 |
| 129 | sleep-maintenance | 3 |
| 130 | tuskegee | 3 |
| 131 | ribosome-free | 1 |
| 132 | seen-the | 1 |
| 133 | ulcer-like | 5 |
| 134 | dysmotility-like | 7 |
| 135 | anti-tnf-eligible | 1 |
| 136 | ultrasound-visible | 4 |
| 137 | ketamine-reversible | 1 |
| 138 | acontractile | 2 |
| 139 | anti-ovine | 1 |
| 140 | mizone | 6 |
| 141 | nonautoimmune | 6 |
| 142 | adult-type | 8 |
| 143 | obesity-type | 4 |
| 144 | effectiveness.point-of-care | 1 |
| 145 | normal-pressure | 4 |
| 146 | dilated-phase | 1 |
| 147 | polyarticular-course | 12 |
| 148 | antibiotic-naive | 1 |
| 149 | muscle-invasive | 109 |
| 150 | non-muscle-invasive | 68 |
| 151 | nonmuscle-invasive | 12 |
| 152 | bh4-responsive | 4 |
| 153 | steroid-unresponsive | 8 |
| 154 | non-massive | 11 |
| 155 | nonocclusive | 9 |
| 156 | angio-obliterative | 2 |
| 157 | normo-active | 1 |
| 158 | oveactive | 1 |
| 159 | underactive | 23 |
| 160 | overactive | 684 |
| 161 | 'overactive | 4 |
| 162 | -overactive | 1 |
| 163 | post-infective | 2 |
| 164 | postinfective | 1 |
| 165 | organ-selective | 5 |
| 166 | unobstructive | 1 |
| 167 | verapamil-sensitive | 1 |
| 168 | moxifloxacin-sensitive | 1 |
| 169 | rifampin-sensitive | 2 |
| 170 | sod1-positive | 1 |
| 171 | tcrb-positive | 5 |
| 172 | antibiotic-naïve | 1 |
| 173 | evidenceof | 1 |
| 174 | muscle-invading | 2 |
| 175 | muscleinvading | 1 |
| 176 | indewelling | 1 |
| 177 | characteristic-appearing | 1 |
| 178 | obliterating | 27 |
| 179 | nonsecreting | 1 |
| 180 | nonresolving | 9 |
| 181 | finch | 25 |
| 182 | intermediate-1-risk | 8 |
| 183 | seborrhoeic/staphylococcal | 1 |
| 184 | sub-clinical | 83 |
| 185 | inflammation/clinical | 3 |
| 186 | infraclinical | 8 |
| 187 | subclinical | 2,357 |
| 188 | overt/subclinical | 1 |
| 189 | extra-vesical | 1 |
| 190 | non-arterial | 2 |
| 191 | bilharzial | 7 |
| 192 | non-bilharzial | 1 |
| 193 | schistosomal | 35 |
| 194 | non-schistosomal | 1 |
| 195 | extraparenchymal | 4 |
| 196 | 'renal | 4 |
| 197 | non-investigated/functional | 1 |
| 198 | involutional | 28 |
| 199 | dextrolateral | 1 |
| 200 | nonurethral | 1 |
| 201 | non-congenital | 2 |
| 202 | cogenital | 1 |
| 203 | nonsegmental | 5 |
| 204 | pre-lingual | 4 |
| 205 | prelingual | 9 |
| 206 | postlingual | 3 |
| 207 | poly-districtual | 1 |
| 208 | clival | 2 |
| 209 | post-withdrawal | 3 |
| 210 | gall | 109 |
| 211 | 3'-full | 1 |
| 212 | /painful | 2 |
| 213 | 1540-nm | 2 |
| 214 | removedfrom | 1 |
| 215 | chlorocadmium | 1 |
| 216 | nepean | 14 |
| 217 | cardiology/european | 5 |
| 218 | postecsarean | 1 |
| 219 | autopsy-proven | 3 |
| 220 | osteodistraction | 4 |
| 221 | post-cesarean-section | 2 |
| 222 | teilo | 2 |
| 223 | papillar | 1 |
| 224 | polyarticular | 29 |
| 225 | ''ocular | 1 |
| 226 | multiocular | 1 |
| 227 | multiglandular | 1 |
| 228 | plasmacellular | 1 |
| 229 | papulopustular | 32 |
| 230 | non-ulcer | 98 |
| 231 | nonulcer | 35 |
| 232 | nonucler | 1 |
| 233 | young-dees-leadbetter | 1 |
| 234 | available.is | 1 |
| 235 | keratitis-ichthyosis | 1 |
| 236 | boari-küss | 1 |
| 237 | urticaria/spontaneous | 1 |
| 238 | non-bullous | 6 |
| 239 | nonbullous | 2 |
| 240 | nonhematogenous | 1 |
| 241 | non-ulcerous | 1 |
| 242 | goitrous | 8 |
| 243 | serum-intact | 1 |
| 244 | systemic-onset | 8 |
| 245 | newly-onset | 2 |
| 246 | t+5-ht | 4 |
| 247 | normal-transit | 1 |
| 248 | slow-transit | 14 |
| 249 | hypocompliant | 4 |
| 250 | drug-intolerant | 2 |
| 251 | clomiphene-resistant | 24 |
| 252 | vancomycine-resistant | 1 |
| 253 | clomiphene-citrate-resistant | 5 |
| 254 | olfloxacin-resistant | 1 |
| 255 | vancomycin-resistant | 162 |
| 256 | anti-vancomycin-resistant | 1 |
| 257 | shunt-dependent | 3 |
| 258 | pth-deficient | 1 |
| 259 | incipient | 168 |
| 260 | mooney-ewart | 1 |
| 261 | tegu | 1 |
| 262 | post-carv | 1 |
| 263 | sub-healthy | 11 |
| 264 | subhealthy | 1 |
| 265 | pre-capillary | 20 |
| 266 | non-medullary | 2 |
| 267 | prymary | 1 |
| 268 | iodine-131-refractory | 1 |
| 269 | dmard-refractory | 3 |
| 270 | nitroimidazole-refractory | 1 |
| 271 | ppi-refractory | 15 |
| 272 | low-capacity | 4 |
| 273 | lazy | 15 |
| 274 | 'lazy | 2 |
| 275 | sensodyne® | 4 |